Clinical Trials List
2023-07-31 - 2031-02-01
Phase III
Recruiting7
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 陳冠宇 Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- 黃俊凱 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- 錢穎群 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 廖唯昱 Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 羅永鴻 Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
- Chia-I Shen Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- 羅永鴻 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chien-Ying Liu Division of General Internal Medicine
- 枋岳甫 Division of General Internal Medicine
- 張境夫 Division of General Internal Medicine
- 邱立忠 Division of General Internal Medicine
- Wen-Cheng Chang Division of General Internal Medicine
- 柯皓文 Division of General Internal Medicine
- 吳教恩 Division of General Internal Medicine
- 黃宗楨 Division of General Internal Medicine
- Cheng-Ta Yang Division of General Internal Medicine
- Chih-Liang Wang Division of General Internal Medicine
- Shih-Hong Li Division of General Internal Medicine
- Jia-Shiuan Ju Division of General Internal Medicine
- Chih-Hung Chen Division of General Internal Medicine
- Chih-Hsi Kuo Division of General Internal Medicine
- 林定佑 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YEN-HSIANG HUANG Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- 李柏昕 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃文聰 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wu-Chou Su Division of Hematology & Oncology
- 蔡政軒 Division of General Internal Medicine
- Po-Lan Su Division of General Internal Medicine
- Seu-Chun Yang Division of General Internal Medicine
- Chun-Hui Lee Division of Hematology & Oncology
- Chin-Wei Kuo Division of General Internal Medicine
- Shang-Yin Wu Division of Hematology & Oncology
- Chian-Wei Chen Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Yen Tu Division of General Internal Medicine
- Chia-Hsiang Li Division of General Internal Medicine
- Yu-Chao Lin Division of General Internal Medicine
- 陳鴻仁 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
22 participants
-
Global
750 participants